Galapagos NV
GLPG
#4738
Rank
โ‚น183.09 B
Marketcap
โ‚น2,726
Share price
-1.14%
Change (1 day)
32.21%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น31.43. In 2024 the company made an earnings per share (EPS) of โ‚น108.01 a decrease over its 2023 EPS that were of โ‚น328.84.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.1%
2024โ‚น108.01-67.16%
2023โ‚น328.84-199.64%
2022-โ‚น330.0299.03%
2021-โ‚น165.82-68.98%
2020-โ‚น534.58-298.06%
2019โ‚น269.91-554.64%
2018-โ‚น59.37-77.18%
2017-โ‚น260.19-326.21%
2016โ‚น115.02-134.19%
2015-โ‚น336.40-371.34%
2014โ‚น123.98-445.98%
2013-โ‚น35.8332.88%
2012-โ‚น26.97-82.07%
2011-โ‚น150.43-817.9%
2010โ‚น20.9512.73%
2009โ‚น18.59-120.79%
2008-โ‚น89.39-37.67%
2007-โ‚น143.4339.64%
2006-โ‚น102.7128.17%
2005-โ‚น80.146.25%
2004-โ‚น75.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,032-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น347.54-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น221.62-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น191.38-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น677.45-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น549.53-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น349.18-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น56.53 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.91-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel